NIHR BioResource Scientific Conference to return in June 2024
NIHR BioResource are excited to announce the NIHR BioResource Scientific Conference will return later this year, hosted online on Wednesday 19 June 2024 from 9.30am to 12.30pm. Leading academics and industry researchers will present their recent work and the unique role of the NIHR BioResource in delivering translational research across a range of disease areas.
Elevating balance and vestibular care at angli-EAR Hearing with the arrival of James Saladine
angli-EAR Hearing proudly welcomes James Saladine, a highly experienced Balance and Vestibular Physiotherapist, to its expert team. With a background in Vestibular Rehabilitation Physiotherapy, James enhances the clinic's offerings, focusing on managing debilitating dizziness symptoms for clients and reducing the risk of falls through unsteadiness.
CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies
Cambridge, UK, and Durham, North Carolina, US - CN Bio and Altis Biosystems, Inc., leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, announces a strategic partnership.
PlaqueTec and the Babraham Institute collaborate on phenotypic screen of coronary artery blood
Collaboration to develop a bespoke cell phenotyping assay for human blood Project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN trial
Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases
· Clinical stage company formed from the merger of Oxitope Pharma and Arxx Therapeutics
Targeting annexin-A1 can halt cancer cell growth
New study shows effectiveness of first drug to focus on cancer-causing protein.
New NHS blood group genotyping test developed with BioResource launches today
From today, almost 18,000 people in England with sickle cell disorder and thalassaemia can have a world-first genetic test to better match future blood transfusions, reducing the risk of side effects.
Arecor granted key european patent extending protection for insulin products, AT278 and AT247
Cambridge, UK - Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, is pleased to announce that the European Patent Office has granted a patent (EP3618840) protecting novel formulations of the Group’s proprietary insulin products, AT278 and AT247.
Seeking managers for research interviews on workplace wellbeing decisions
The UEA workplace wellbeing team calls for UK managers of any level, any sector, to take part in new research about decision-making on workplace wellbeing activities.
Role of inherited genetic variants in rare blood cancer uncovered
Large-scale genetic analysis has helped researchers uncover the interplay between cancer-driving genetic mutations and inherited genetic variants in a rare type of blood cancer.
Abzena launches AbZelect CLD platforms
Abzena launches AbZelect™ platforms for improving cell line development efficiency on the pathway to IND.
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindness
The emerging business models for digital therapeutics
This article was originally published at Med Device Online.
Guardtech pledge to support NHS aseptic pharmacy units in 2024 after spike in enquiries
The Haverhill cleanroom construction experts have been inundated with enquiries from the nation’s healthcare heroes in recent months
Supporting a Phase III R&D strategy within the anti-infective space
Client Issue An emerging pharmaceutical company sought to evaluate Phase III development strategies for an anti-infective drug with potential to treat a range of patient populations.
A complimentary Cost-Savings Audit Breathe Technology
Breathe Technology is currently providing a free, cost-savings audit. A friendly, no-obligation and knowledgeable service.
Establishing real-world testing and treatment patterns for EGFR NSCLC patients
Client issue Oncology-focused biotech was looking to establish real-world testing and treatment patterns among EGFR NSCLC patients in US, EU, Japan, and Greater China (mainland, HK, and Taiwan).
Antibiotic use is not the only driver of superbugs
For the first time, researchers have analysed the impact of antibiotic use on the rise of treatment-resistant bacteria over the last 20 years in the UK and Norway. They show that while the increase in drug use has amplified the spread of superbugs, it is not the only driver.
Cancer drug discovery accelerated as hundreds of overlooked targets prioritised
A new, systematic analysis of cancer cells identifies 370 candidate priority drug targets across 27 cancer types, including breast, lung and ovarian cancers.
Rare Disease: 2023 in Review
As we look back at another busy year for the rare disease (RD) space, we also reflect on the continued growth of CRA’s rare disease capabilities and offerings.
How to start your health journey: key health skills for success
Creative Nutritionist writes...Happy New Year everyone! I hope you had a lovely Christmas break.
If you are starting your health journey this January, and you are a bit confused as to what to do- don’t worry! I have you covered.
Prism facilitate sale of Cambridge-based medtech design consultancy
Prism Corporate Broking are pleased to announce that we have facilitated the sale of medtech device design and development consultancy, Springboard Pro Ltd, to leading global healthcare packaging and medical device manufacturers, Sanner GmbH (Sanner Group), a company backed by Europe’s leading healthcare specialist private equity investor, GHO Capital.
Tributes roll in for transplant pioneer Sir Roy
Addenbrooke’s Hospital staff have been paying tribute to pioneering transplant surgeon, Sir Roy Calne, who died over the weekend, aged 93.
Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders
Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives